Stocks and Investing
Stocks and Investing
Wed, June 6, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, June 5, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, June 4, 2018
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jim Birchenough Maintained (ZYME) at Buy with Increased Target to $37 on, Jun 4th, 2018
Jim Birchenough of Wells Fargo, Maintained "Zymeworks Inc." (ZYME) at Buy with Increased Target from $20 to $37 on, Jun 4th, 2018.
Jim has made no other calls on ZYME in the last 4 months.
There are 2 other peers that have a rating on ZYME. Out of the 2 peers that are also analyzing ZYME, 1 agrees with Jim's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Geoff Meacham of "Barclays" Upgraded from Sell to Hold on, Friday, May 11th, 2018
This is the rating of the analyst that currently disagrees with Jim
- David Novak of "Raymond James" Initiated at Buy on, Monday, March 19th, 2018
Contributing Sources